Ibrutinib, (brand name Imbruvica), Can Keep Leukemia in Remission for Years in Younger Patients

TUESDAY, Dec. 14, 2021 -- For certain leukemia patients, some welcome findings: New research confirms long remissions after treatment with the drug ibrutinib and chemotherapy. The study involved 85 patients with chronic lymphocytic leukemia (CLL)....
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news